Temporary Equity, Stockholders' Deficit and Warrants (Tables)

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

Summary Of Warrants Activity

A summary of warrants activity for the year ended December 31, 2021 and 2022 is as follows:

	Number of Warrants
	Equity Classified			Liability Classified
Balance at December 31, 2021		8,856,255			16,022,000
Issued in 2021		2,231,453			—
Balance at December 31, 2021		11,087,708			16,022,000
Issued in 2022		119,347,471			356,138,415
Reclassified in 2022		28,377,564			(28,377,564	)
Exercised in 2022		(75,650,083	)		(341,566,839	)
Forfeited in 2022		(103,334	)		—
Balance at December 31, 2022		83,059,326			2,216,012

Summary of Activity for Warrants Outstanding

The Company reclassified to equity all of its liability classified warrants with exercise prices greater than $0.01 on September 8, 2022. The warrants were amended to modify certain anti-dilution features and they became indexed to EVO’s common stock.

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term
December 31, 2022:
Outstanding		2,216,012	$	0.01		4.3
Exercisable		2,216,012	$	0.01
December 31, 2021:
Outstanding		16,022,000	$	0.52		4.8
Exercisable		16,022,000	$	0.52

In addition to the liability-classified warrants, EVO has issued warrants with different terms that are considered indexed to EVOs common stock and, therefore, are classified in additional paid-in capital and are not required to be measured at fair value

at each reporting date. The following table summarizes such equity-classified warrants outstanding and exercisable as of December 31, 2022 and 2021 and is inclusive of the warrants disclosed in Note 7, Stock-Based Compensation, that are equity-classified:

	Number of Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Term
December 31, 2022:
Outstanding		83,059,326	$	0.85		4.9
Exercisable		83,059,326	$	0.85
December 31, 2021:
Outstanding		11,087,708	$	2.37		6.9
Exercisable		11,087,708	$	2.37